PAT-1251
CAS No. 2007885-39-2
PAT-1251 ( PAT 1251;PAT1251 )
产品货号. M13132 CAS No. 2007885-39-2
PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥4026 | 有现货 |
|
10MG | ¥5856 | 有现货 |
|
25MG | ¥9153 | 有现货 |
|
50MG | ¥12312 | 有现货 |
|
100MG | ¥16038 | 有现货 |
|
500MG | ¥32157 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PAT-1251
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
-
产品描述PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays, with high selectivity over LOX (400-fold) and other amine oxidases; exhibits efficacy in mouse bleomycin lung fibrosis model.Fibrosis Phase 1 Clinical
-
同义词PAT 1251;PAT1251
-
通路Others
-
靶点Other Targets
-
受体Other Targets
-
研究领域Other Indications
-
适应症Fibrosis
化学信息
-
CAS Number2007885-39-2
-
分子量399.35
-
分子式C18H17F4N3O3
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 130 mg/mL 325.54 mM
-
SMILESO=C(C1=CC=CC(OC2=NC(C(F)(F)F)=CC(CN)=C2)=C1)N3C[C@@H](F)[C@H](O)C3
-
化学全称(3-((4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)((3R,4R)-3-fluoro-4-hydroxypyrrolidin-1-yl)methanone
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Rowbottom MW, et al. J Med Chem. 2017 May 25;60(10):4403-4423.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Bicine
Bicine is an organic compound used as a biological buffer.